Drug
Stx 721 Pfl 721
Stx 721 Pfl 721: highest development phase Phase 1/2, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| STX-721/PFL-721 (Escalated) NCT06043817 | Phase 1/2 | Non-Small Cell Lung Cancer |
Latest
No recent events.
Follow Stx 721 Pfl 721 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.